TPG related stories
All articles and analysis
- TPG-led group to inject $7bn into WaMu
TPG co-founder David Bonderman will rejoin the troubled Seattle-based savings and loan.
- TPG to pay $1.3bn for Canadian drug firm(4)
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
- SVG writes down Permira deals to tune of £67m
The listed alternative asset manager incurred losses on its investments in four Permira portfolio companies last year, but its fund management business grew and Permira made ten profitable realisations.
- Fine for now
Fundraising is proceeding at a fair clip amid signs that even the larger funds are still in favour. It is clear that investors are keeping the faith. But will they do so indefinitely, asks Andy Thomson?
- HRJ closes $195m special situations FoF
The San Francisco-based firm co-founded by American football Hall of Famer Ronnie Lott has fully committed its latest fund.
- TPG to pay $1.3bn for Canadian drug firm(3)
Axcan Pharma has agreed to be taken private by TPG in a transaction valued at $1.3 billion. It’s the firm’s third healthcare acquisition this year.
- Conversus commits $70m to TPG and TowerBrook funds
Despite further gains in its portfolio’s value the fund of funds' discount to NAV is increasing as listed private equity firms continue to suffer.
- TPG, Bain, Goldman to sell $450m of Burger King stock(2)
The private equity consortium that five years ago paid $1.5 billion for Burger King continues to profit from its investment in the fast food chain. A secondary offering will raise $450 million for the firms.
- TPG seals Russia’s largest buyout deal
TPG's $800m pure equity stake in the country's biggest pharmaceutical distributor should allow the global buyout firm to tap into the fast-growing Russian market.
- Virginia Retirement increases private equity allocation
The state retirement system has increased private equity and real estate allocations by 3 percent, saying it wants more flexibility in its investments.